BOS Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

BOS Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,640	Closed	-$252K	–	158
2024 Q1	$252K	Sell	4,640 -1,800	-28%	-$91.7K	0.13%	128
2023 Q4	$330K	Sell	6,440 -750	-10%	-$39.4K	0.23%	98
2023 Q3	$417K	Sell	7,190 -328	-4%	-$20.1K	0.31%	74
2023 Q2	$481K	Hold	7,518	–	–	0.37%	62
2023 Q1	$521K	Sell	7,518 -300	-4%	-$21.2K	0.43%	58
2022 Q4	$563K	Buy	+7,818	New	+$589K	0.5%	51

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOS Asset Management's BMY Position: Q2 2024 in Review

BOS Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 4,640 shares — an estimated $252K sold.

BOS Asset Management first reported a position in BMY in Q4 2022 and held it in 6 quarters. The position peaked at $563K in Q4 2022. 2,153 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

BOS Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
BOS Asset Management sold 4,640 Bristol-Myers Squibb shares in Q2 2024, an estimated $252K.
BOS Asset Management first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 6 quarters.
BOS Asset Management's Bristol-Myers Squibb position peaked at $563K in Q4 2022.
2,153 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on BOS Asset Management's 13F filing for Q2 2024, filed 30 Jul 2024.